Table 4 Association of 1-SD increment in AD polygenic score with cognitive function in ADNI.

From: Association of genetic risk of Alzheimer’s disease and cognitive function in two European populations

Cognitive functions

Cognitive normal

Mild cognitive impairment

Model 1

Model 2

Model 1

Model 2

Beta (SE)

P value

Beta (SE)

P value

Beta (SE)

P value

Beta (SE)

P value

Mini-Mental State Exam, MMSE

− 0.074 (0.026)

4.89E−03

− 0.067 (0.030)

0.03

− 0.218 (0.041)

1.46E−07

− 0.076 (0.047)

0.10

Alzheimer Disease Assessment Scale 11

0.089 (0.029)

2.63E−03

0.079 (0.033)

0.02

0.252 (0.041)

2.32E−09

0.118 (0.047)

0.01

Alzheimer Disease Assessment Scale 13

0.094 (0.032)

4.01E−03

0.082 (0.037)

0.03

0.254 (0.042)

3.67E−09

0.109 (0.048)

0.02

Montreal Cognitive Assessment

− 0.067 (0.038)

0.08

− 0.050 (0.043)

0.24

− 0.252 (0.047)

1.12E−07

− 0.094 (0.053)

0.08

Functional Assessment Questionnaire

0.057 (0.027)

0.03

0.053 (0.030)

0.08

0.211 (0.044)

1.92E−06

0.055 (0.050)

0.27

ADNI memory summary score

− 0.084 (0.042)

0.05

− 0.073 (0.048)

0.13

− 0.226 (0.039)

2.06E−08

− 0.085 (0.045)

0.06

ADNI executive function score

− 0.061 (0.043)

0.16

− 0.049 (0.048)

0.31

− 0.106 (0.040)

7.27E03

0.005 (0.046)

0.90

ADNI language summary score

− 0.035 (0.042)

0.41

− 0.054 (0.048)

0.26

− 0.157 (0.040)

8.55E−05

− 0.066 (0.047)

0.15

ADNI visuospatial summary score

− 0.013 (0.037)

0.73

− 0.016 (0.042)

0.70

− 0.066 (0.035)

0.06

0.023 (0.041)

0.58

  1. Mixed effects linear regression model:
  2. Model 1: age at the visit, sex, education, ever vs. never smokers, BMI, 10 PC adjusted.
  3. Model 2: Model 1 + APOE4 risk allele dosages.
  4. Cognitive function were in bold as all statistically significant (P value < 0.0056) across all the models, were in italic if only significant in some of the models.